POU4F2: A Drug Target / Disease Biomarker (G5458)

Target Name: POU4F2

NCBI ID: G5458

POU4F2

POU4F2: A Drug Target / Disease Biomarker

POU4F2, also known as protamineuron, is a gene that has been identified as a potential drug target or biomarker for the treatment of various neurological disorders, including Alzheimer's disease, Parkinson's disease, and multiple sclerosis. The protein encoded by the POU4F2 gene is involved in the production of a protein called protamineuron, which is known to play a role in the production of dopamine in the brain.

Initial studies on POU4F2 identified a link between the gene and the development of neurological disorders. Researchers found that individuals with certain genetic variations in the POU4F2 gene were more likely to develop Alzheimer's disease or other forms of dementia. Additionally, individuals with certain genetic variations in the POU4F2 gene were also more likely to have symptoms of Parkinson's disease, such as tremors and stiffness.

Further studies have shown that POU4F2 is involved in the production of the protein tau, which is known to play a role in the development of neurodegenerative disorders. tau is a protein that is found in the brain and is involved in the production of dopamine, as well as other neurotransmitters. Studies have shown that tau is often abnormally produced in individuals with neurodegenerative disorders, and that this production is linked to the progression of the disease.

Research also suggests that POU4F2 may be involved in the production of other proteins that are involved in the development and progression of neurological disorders. For example, studies have shown that POU4F2 is involved in the production of the protein S100, which is known to play a role in the development of neurodegenerative disorders. Additionally, POU4F2 has been shown to be involved in the production of the protein USP9, which is known to play a role in the production of dopamine in the brain.

Despite these promising findings, more research is needed to fully understand the role of POU4F2 in the development and progression of neurological disorders. Additionally, it is important to consider the potential implications of POU4F2 as a drug target or biomarker, and to further research is needed to determine the efficacy and safety of using POU4F2 as a treatment for neurological disorders.

In conclusion, POU4F2 is a gene that has been identified as a potential drug target or biomarker for the treatment of various neurological disorders. The protein encoded by the POU4F2 gene is involved in the production of a protein called protamineuron, which is known to play a role in the production of dopamine in the brain. Further research is needed to fully understand the role of POU4F2 in the development and progression of neurological disorders, as well as its potential as a drug target or biomarker.

Protein Name: POU Class 4 Homeobox 2

Functions: Tissue-specific DNA-binding transcription factor involved in the development and differentiation of target cells (PubMed:19266028, PubMed:23805044). Functions either as activator or repressor modulating the rate of target gene transcription through RNA polymerase II enzyme in a promoter-dependent manner (PubMed:19266028, PubMed:23805044). Binds to the consensus octamer motif 5'-AT[A/T]A[T/A]T[A/T]A-3' of promoter of target genes. Plays a fundamental role in the gene regulatory network essential for retinal ganglion cell (RGC) differentiation. Binds to an octamer site to form a ternary complex with ISL1; cooperates positively with ISL1 and ISL2 to potentiate transcriptional activation of RGC target genes being involved in RGC fate commitment in the developing retina and RGC axon formation and pathfinding. Inhibits DLX1 and DLX2 transcriptional activities preventing DLX1- and DLX2-mediated ability to promote amacrine cell fate specification. In cooperation with TP53 potentiates transcriptional activation of BAX promoter activity increasing neuronal cell apoptosis. Negatively regulates BAX promoter activity in the absence of TP53. Acts as a transcriptional coactivator via its interaction with the transcription factor ESR1 by enhancing its effect on estrogen response element (ERE)-containing promoter. Antagonizes the transcriptional stimulatory activity of POU4F1 by preventing its binding to an octamer motif. Involved in TNFSF11-mediated terminal osteoclast differentiation (By similarity)

The "POU4F2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about POU4F2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets